1117 ECP LifeEDIT
BioCentury & Getty Images

Emerging Company Profile 

Led by ElevateBio’s Finer, LifeEDIT is pursuing novel enzymes for gene editing

Emerging Company Profile: AgBiome spinout LifeEDIT gains funding, gene and cell therapy expertise from ElevateBio

AgBiome spinout LifeEDIT Therapeutics gains funding, gene and cell therapy expertise and manufacturing resources from ElevateBio. 

Nov 18, 2020 | 2:12 AM GMT

LifeEDIT debuted with

Read the full 585 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE